Concepedia

Author

Ruth Volland

University Hospital Cologne

Also Known As

Christine Höfer, R Volland, R. Volland, Ruth Volland, Thomas Friess

70

Publications

2.5K

Citations

22

H-Index

51

Concepts

All Affiliations

University Hospital CologneUniversity of CologneHeidelberg UniversityGerman Cancer Research CenterCharité - Universitätsmedizin Berlin
RV

About

Ruth Volland is an author at University Hospital Cologne specializing in medicine, cell biology, and neuro-oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

10

10

958

2

Cell Biology

5

5

837

3

Health Sciences

1

1

37

4

Public Health

1

1

18

5

Emergency Medicine

1

1

30

Ruth Volland

×

26

Publications

2.4K

Citations

22

H-Index

YearCitations

Telomerase activation by genomic rearrangements in high-risk neuroblastoma

Martin Peifer, Falk Hertwig, Frederik Roels,

Nature

2015

577

Comparison of RNA-seq and microarray-based models for clinical endpoint prediction

Wenqian Zhang, Ying Yu, Falk Hertwig,

Genome Biology

2015

416

A mechanistic classification of clinical phenotypes in neuroblastoma

Sandra Ackermann, Maria Cartolano, Barbara Hero,

Science

2018

319

Sense-Antisense lncRNA Pair Encoded by Locus 6p22.3 Determines Neuroblastoma Susceptibility via the USP36-CHD7-SOX9 Regulatory Axis

Tanmoy Mondal, Prasanna Kumar Juvvuna, Agnete Kirkeby,

Cancer Cell

2018

137

Vitamin B6 in Primary Hyperoxaluria I

Heike Hoyer‐Kuhn, Sina Kohbrok, Ruth Volland,

Clinical Journal of the American Society of Nephrology

2014

134

Iodine-123 Metaiodobenzylguanidine Scintigraphy Scoring Allows Prediction of Outcome in Patients With Stage 4 Neuroblastoma: Results of the Cologne Interscore Comparison Study

Boris Decarolis, Christina Schneider, Barbara Hero,

Journal of Clinical Oncology

2013

99

Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic Markers

André Oberthuer, Dilafruz Juraeva, Barbara Hero,

Clinical Cancer Research

2014

98

Complete surgical resection improves outcome in INRG high-risk patients with localized neuroblastoma older than 18 months

J. Fischer, Alexandra Pohl, Ruth Volland,

BMC Cancer

2017

81

Lack of immunocytological GD2 expression on neuroblastoma cells in bone marrow at diagnosis, during treatment, and at recurrence*

Roswitha Schumacher‐Kuckelkorn, Ruth Volland, Anke Gradehandt,

Pediatric Blood & Cancer

2016

65

Extended induction chemotherapy does not improve the outcome for high-risk neuroblastoma patients: results of the randomized open-label GPOH trial NB2004-HR

Frank Berthold, Andreas Faldum, Angela Ernst,

Annals of Oncology

2020

58

Page 1